(Q43430812)

23 November 2017

title

Psychiatric morbidity and its effect on the quality of life of patients with chronic hepatitis B and hepatitis C. (English)

1 reference

23 November 2017

1 reference

1 reference

9

Nazmiye Kocaman

1 reference

23 November 2017

Mine Ozkan

1

1 reference

23 November 2017

Aytül Corapçioglu

2

1 reference

23 November 2017

Ibrahim Balcioglu

3

1 reference

23 November 2017

Erhan Ertekin

4

1 reference

23 November 2017

Sila Khan

5

1 reference

23 November 2017

Samuray Ozdemir

6

1 reference

23 November 2017

Deniz Karayün

7

1 reference

23 November 2017

Bariş Onen Unsalver

8

1 reference

23 November 2017

Sabahattin Kaymakglu

10

1 reference

23 November 2017

Gültürk Köroglu

11

1 reference

23 November 2017

publication date

1 January 2006

1 reference

International Journal of Psychiatry in Medicine

23 November 2017

published in

1 reference

23 November 2017

volume

36

1 reference

23 November 2017

issue

3

1 reference

23 November 2017

page(s)

283-297

1 reference

Hepatitis C: the clinical spectrum of disease

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Epidemiology of hepatitis C in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Depression in Korean immigrants with hepatitis B and related liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Psychiatric comorbidity among hepatitis C-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Psychiatric disorders and functioning in hepatitis B virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Hepatitis C, interferon alfa, and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Morbidity of chronic hepatitis C as seen in a tertiary care medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Psychiatric disorders among veterans with hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Depression, anxiety, post-traumatic stress, and alcohol-related problems among veterans with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Psychiatric disorder in a sample of the general population with and without chronic medical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Psychiatric morbidity in terminally ill cancer patients. A prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Depression, fatigue, and functional disability in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Health assessment for chronic HCV infection: results of quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Is severe liver disease a common outcome for people with chronic hepatitis C?

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Emotional distress in chronic hepatitis C patients not receiving antiviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Impact of psychiatric conditions on health-related quality of life in persons with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

The effects of psychiatric disorders and symptoms on quality of life in patients with type I and type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Quality of life in HCV-infection: lack of association with ALT levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

Functional status in coronary artery disease: a one-year prospective study of the role of anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FD37Y-X0JY-39MJ-PVXQ

10.2190/D37Y-X0JY-39MJ-PVXQ

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference